Leveraging Model-Informed Drug Development to Predict Asciminib Efficacy in Second-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase

Clinical Pharmacokinetics 2026

View at publisher
Authors: Sherwin K. B. Sy, Deok Yong Yoon, Yiqun Yang, Christelle Darstein, Kohinoor Dasgupta, Shruti Kapoor, Shengyuan Wu, Yasunori Kawakita, Matthias Hoch, Kai Grosch
DOI: 10.1007/s40262-025-01616-y
Cited by: 0
References: 44

Fields of Study & Subjects

Chronic Myeloid Leukemia Treatments Statistical Methods in Clinical Trials Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Clinical Pharmacokinetics
Volume
65
Issue
4
Pages
595–608
Publication date
11 February 2026
Language
EN